Potential therapeutic targets for obstructive sleep Apnea were identified through network pharmacology, WGCNA, machine learning, immune infiltration analysis, and ceRNA network
Integrative Biology · 16.01.2026 · 18
DOI: 10.1093/intbio/zyag013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Biology, online erschienen am 31.07.2026. Verfasst von Fengwei Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524023, Guangdong, China. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Machine Learning, Gene Regulatory Networks, Network Pharmacology. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Guang dong Medical Research Fund Project, Zhanjiang Science and Technology Research Project in 2024, the High-level Talents Scientific Research Start-up Funds of the Affiliated Hospital of Guangdong Medical University.
Abstract (Originalsprache)
Background
Our study aims to explore the early genomic diagnostic markers of OSA and the corresponding drug prediction targets using network pharmacology analysis, and to elucidate the etiology and pathogenesis of OSA from the genetic level.
Methods
We selected OSA-related gene datasets (GSE135917 and GSE38792) from the Gene Expression Omnibus (GEO). Principal component analysis (PCA) was performed to remove outlier samples, and batch correction was applied to the two datasets. The raw expression matrix was log2-transformed, and samples were divided into normal and OSA groups. Differentially expressed genes (DEGs) were identified, and WGCNA analysis was performed on these DEGs to identify mitochondria-associated hub genes, followed by functional enrichment analysis, PPI network construction, core lncRNA-related ceRNA network construction. We then screened core genes with a high risk of OSA. Based on the core genes, we established an easy-to-use nomogram and verified its accuracy in identifying OSA patients then performed a differential expression analysis of the core genes, GSEA and GSVA analyses, and immune infiltration analysis. Finally, we constructed the disease prediction model and predicted the drug targets, thereby obtain a genomic prediction model for OSA.
Results
After PCA and batch correction, an expression matrix comprising 13 normal samples and 19 OSA patient samples was finally included. We identified 1500 differentially expressed genes (DEGs) through differential expression analysis, then screened 61 hub genes by WGCNA analysis, and established an OSA-associated ceRNA network containing 75 predictive miRNAs, 129 lncRNAs and 5 mRNAs. Six robust key genes were identified through PPI network construction: TUFM, CYCS, UQCRC1, COX4I1, TIMM50, and NDUFV1. Finally, after LASSO regression and nomogram validation, a predictive model containing 2 core genes (UQCRC1 and COX4I1) was obtained, and its area under the ROC curve (AUC) was 0.919. Drug target prediction of the core genes showed that 1-Methyl-4-phenyl-2,3-dihydropyridinium CTD 00002003, Cube root extract CTD 00006707, Disodium selenite CTD 00007229, and mitotane CTD 00006344 had good effects.
Conclusion
Our current findings provide a rationale for identifying therapeutic targets in the diagnosis and treatment of OSA. In addition, these findings have the potential to facilitate the translation of our study to clinical applications in the future. Insight Box Different from other single-gene predictors of OSA, network pharmacological analysis identified differential genes and explored biomolecular markers of OSA from multi-gene and multi-target perspectives through enrichment analysis, construction of ceRNA gene network, and correlation analysis and explore early genomic diagnostic indicators of OSA and corresponding drug prediction targets using network pharmacological analysis and to elucidate the etiology and pathogenesis of OSA from the genetic level. To provide a more accurate method for the diagnosis, prevention, and treatment of clinical OSA, it is expected to provide a research basis for the accurate diagnosis of clinical OSA and the pathogenesis of OSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524023, Guangdong, China.
ORCID-Profile: Dikun Zhu, Dingyu Guo, Tianhuang Yuan
Förderung
- Guang dong Medical Research Fund Project
- Zhanjiang Science and Technology Research Project in 2024
- the High-level Talents Scientific Research Start-up Funds of the Affiliated Hospital of Guangdong Medical University
Zitieren
APA
Xie, F., Zhu, D., Yang, Z., Sun, J., Huang, T., Xian, Q., Guo, D., Lin, Y., Song, L., Zhong, M., Liu, Y., Yuan, T., Pang, L., & Sun, X. (2026). Potential therapeutic targets for obstructive sleep Apnea were identified through network pharmacology, WGCNA, machine learning, immune infiltration analysis, and ceRNA network. Integrative Biology, 18. https://doi.org/10.1093/intbio/zyag013
Vancouver
Xie F, Zhu D, Yang Z, Sun J, Huang T, Xian Q, et al. Potential therapeutic targets for obstructive sleep Apnea were identified through network pharmacology, WGCNA, machine learning, immune infiltration analysis, and ceRNA network. Integrative Biology. 2026;18. doi:10.1093/intbio/zyag013
BibTeX
@article{Xie2026,
author = {Xie, Fengwei and Zhu, Dikun and Yang, Zhitong and Sun, Jie and Huang, Tao and Xian, Qian and Guo, Dingyu and Lin, Yuyin and Song, Lingyue and Zhong, Ming and Liu, Yiming and Yuan, Tianhuang and Pang, Lingpin and Sun, Xishi},
title = {Potential therapeutic targets for obstructive sleep Apnea were identified through network pharmacology, WGCNA, machine learning, immune infiltration analysis, and ceRNA network},
journal = {Integrative Biology},
year = {2026},
volume = {18},
doi = {10.1093/intbio/zyag013}
}
EUVIMED